BSE Live
Sep 05, 16:01Prev. Close
1338.25
Open Price
1334.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 05, 15:54Prev. Close
1339.20
Open Price
1337.60
Bid Price (Qty.)
1335.00 (20)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Ipca Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 | |
Total Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 | |
Reserves and Surplus | 6,866.25 | 6,323.34 | 5,851.93 | 5,497.97 | 4,727.35 | |
Total Reserves and Surplus | 6,866.25 | 6,323.34 | 5,851.93 | 5,497.97 | 4,727.35 | |
Total Shareholders Funds | 6,891.62 | 6,348.71 | 5,877.30 | 5,523.34 | 4,752.72 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 482.43 | 542.19 | 651.78 | 395.18 | 9.13 | |
Deferred Tax Liabilities [Net] | 191.20 | 183.09 | 179.45 | 155.14 | 135.00 | |
Other Long Term Liabilities | 28.38 | 14.62 | 14.09 | 12.92 | 10.40 | |
Long Term Provisions | 57.76 | 50.49 | 46.57 | 40.98 | 37.29 | |
Total Non-Current Liabilities | 759.77 | 790.39 | 891.89 | 604.22 | 191.82 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 389.30 | 590.72 | 770.83 | 365.83 | 214.07 | |
Trade Payables | 481.53 | 422.74 | 450.84 | 480.41 | 526.46 | |
Other Current Liabilities | 417.60 | 397.63 | 348.24 | 392.44 | 222.78 | |
Short Term Provisions | 131.10 | 109.08 | 107.87 | 100.62 | 102.28 | |
Total Current Liabilities | 1,419.53 | 1,520.17 | 1,677.78 | 1,339.30 | 1,065.59 | |
Total Capital And Liabilities | 9,070.92 | 8,659.27 | 8,446.97 | 7,466.86 | 6,010.13 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 2,502.78 | 2,502.09 | 2,454.58 | 2,057.31 | 1,839.75 | |
Intangible Assets | 33.93 | 21.47 | 24.08 | 27.47 | 28.85 | |
Capital Work-In-Progress | 484.05 | 165.59 | 114.31 | 285.29 | 180.85 | |
Other Assets | 0.26 | 0.14 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 3,026.62 | 2,698.90 | 2,601.68 | 2,373.82 | 2,050.60 | |
Non-Current Investments | 2,041.32 | 2,243.56 | 733.41 | 728.21 | 474.01 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 31.96 | 88.20 | 115.86 | 63.88 | 138.95 | |
Other Non-Current Assets | 152.97 | 118.72 | 120.87 | 110.03 | 68.78 | |
Total Non-Current Assets | 5,252.87 | 5,149.38 | 3,571.82 | 3,275.94 | 2,732.34 | |
CURRENT ASSETS | ||||||
Current Investments | 651.94 | 410.60 | 323.32 | 719.31 | 393.83 | |
Inventories | 1,542.39 | 1,677.09 | 1,660.13 | 1,750.15 | 1,517.09 | |
Trade Receivables | 1,154.61 | 1,027.40 | 925.90 | 815.94 | 774.46 | |
Cash And Cash Equivalents | 164.53 | 112.92 | 1,706.06 | 592.97 | 306.92 | |
Short Term Loans And Advances | 40.37 | 5.43 | 1.03 | 7.46 | 19.96 | |
OtherCurrentAssets | 264.21 | 276.45 | 258.71 | 305.09 | 265.53 | |
Total Current Assets | 3,818.05 | 3,509.89 | 4,875.15 | 4,190.92 | 3,277.79 | |
Total Assets | 9,070.92 | 8,659.27 | 8,446.97 | 7,466.86 | 6,010.13 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 490.63 | 308.45 | 2,161.85 | 287.71 | 382.20 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 717.42 | 727.91 | 817.75 | 893.54 | 794.87 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 2,808.96 | 2,707.70 | 2,643.42 | 2,502.69 | 2,717.19 | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 10.45 | 10.45 | 10.45 | 10.45 | 20.90 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 2,788.11 | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 629.00 | 18.60 | 25.41 | 25.19 | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 651.94 | 410.60 | 323.32 | 719.31 | 393.83 | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
13.08.2025
Accumulate Ipca Laboratories; target of Rs 1525: Prabhudas Lilladher
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
03.06.2025
Ipca Labs Consolidated March 2025 Net Sales at Rs 2,246.69 crore, up 10.51% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
03.06.2025
Ipca Labs Consolidated March 2025 Net Sales at Rs 2,246.69 crore, up 10.51% Y-o-Y
04.03.2025
Ipca Labs Consolidated December 2024 Net Sales at Rs 2,245.37 crore, up 9.38% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher